BIO vs. BA
BIO (Bio-Rad Laboratories, Inc.) and BA (The Boeing Company) are both stocks. BIO operates in Medical Devices (Healthcare), while BA operates in Aerospace & Defense (Industrials). Over the past 10 years, BIO returned 8.34%/yr vs 6.05%/yr for BA. Their 0.21 correlation means their historical movements had little consistent relationship.
Performance
BIO vs. BA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIO achieves a 7.42% return, which is significantly higher than BA's -0.45% return. Over the past 10 years, BIO has outperformed BA with an annualized return of 8.34%, while BA has yielded a comparatively lower 6.05% annualized return.
BIO
- 1D
- -0.38%
- 1M
- 9.64%
- 6M
- 10.82%
- YTD
- 7.42%
- 1Y
- 14.36%
- 3Y*
- -7.20%
- 5Y*
- -15.14%
- 10Y*
- 8.34%
- ALL TIME*
- 9.37%
BA
- 1D
- -2.15%
- 1M
- -4.57%
- 6M
- -7.52%
- YTD
- -0.45%
- 1Y
- -2.60%
- 3Y*
- -3.16%
- 5Y*
- -0.93%
- 10Y*
- 6.05%
- ALL TIME*
- 10.14%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $1.48B | $1.24B | $1.42B | |
| $108.65M | $93.16M | $109.24M |
BIO vs. BA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIO Bio-Rad Laboratories, Inc. | 7.42% | -7.77% | 1.74% | -23.21% | -44.35% | 29.61% | 57.54% | 59.34% | -2.70% | 30.94% |
BA The Boeing Company | -0.45% | 22.67% | -32.10% | 36.84% | -5.38% | -5.95% | -33.90% | 3.34% | 11.50% | 94.72% |
Correlation
The correlation between BIO and BA is 0.18, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.18 |
Correlation (3Y) Balances recent behavior with more history. | 0.21 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.23 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.21 |
Correlation (All Time) Calculated using the full available price history since Feb 27, 1980 | 0.21 |
Fundamentals
BIO:
$8.80B
BA:
$170.83B
BIO:
$6.26
BA:
$3.08
BIO:
51.99
BA:
70.14
BIO:
0.48
BA:
10.99
BIO:
3.39
BA:
1.82
BIO:
1.28
BA:
28.06
BIO:
$2.59B
BA:
$94.00B
BIO:
$1.34B
BA:
$4.40B
BIO:
$746.20M
BA:
$6.95B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIO vs. BA — Risk / Return Rank
BIO
BA
BIO vs. BA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Bio-Rad Laboratories, Inc. (BIO) and The Boeing Company (BA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIO | BA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.91 | ||
| Sortino ratioReturn per unit of downside risk | +1.40 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.01 | +0.18 |
| Calmar ratioReturn relative to maximum drawdown | 1.20 | -0.10 | +1.31 |
| Martin ratioReturn relative to average drawdown | 2.67 | -0.22 | +2.88 |
Loading charts...
Drawdowns
BIO vs. BA - Drawdown Comparison
The maximum BIO drawdown since its inception was -83.64%, smaller than the maximum BA drawdown of -89.45%. Use the drawdown chart below to compare losses from any high point for BIO and BA.
Loading charts...
Drawdown Indicators
| BIO | BA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.64% | -89.45% | +5.81% |
Max Drawdown (1Y)Largest decline over 1 year | -28.86% | -24.96% | -3.90% |
Max Drawdown (3Y)Largest decline over 3 years | -46.24% | -48.31% | +2.07% |
Max Drawdown (5Y)Largest decline over 5 years | -73.77% | -51.62% | -22.15% |
Max Drawdown (10Y)Largest decline over 10 years | -73.77% | -77.92% | +4.15% |
Current DrawdownCurrent decline from peak | -60.58% | -49.77% | -10.81% |
Average DrawdownAverage peak-to-trough decline | -27.85% | -31.06% | +3.21% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.97% | 11.94% | +1.03% |
Volatility
BIO vs. BA - Volatility Comparison
The current volatility for Bio-Rad Laboratories, Inc. (BIO) is 8.54%, while The Boeing Company (BA) has a volatility of 10.83%. This indicates that BIO experiences smaller price fluctuations and is considered to be less risky than BA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIO | BA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.54% | 10.83% | -2.29% |
Volatility (6M)Calculated over the trailing 6-month period | 30.08% | 24.73% | +5.35% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.91% | 32.64% | +9.27% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.59% | 36.54% | +1.05% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.23% | 41.70% | -7.47% |
Dividends
BIO vs. BA - Dividend Comparison
Neither BIO nor BA has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BA The Boeing Company | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.96% | 2.52% | 2.12% | 1.93% | 2.80% | 2.52% |
BIO Bio-Rad Laboratories, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
BIO vs. BA - Financials Comparison
This section allows you to compare key financial metrics between Bio-Rad Laboratories, Inc. and The Boeing Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
BIO vs. BA - Profitability Comparison
BIO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Bio-Rad Laboratories, Inc. reported a gross profit of 309.40M and revenue of 592.10M. Therefore, the gross margin over that period was 52.3%.
BA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, The Boeing Company reported a gross profit of 2.41B and revenue of 24.56B. Therefore, the gross margin over that period was 9.8%.
BIO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Bio-Rad Laboratories, Inc. reported an operating income of 34.10M and revenue of 592.10M, resulting in an operating margin of 5.8%.
BA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, The Boeing Company reported an operating income of 78.00M and revenue of 24.56B, resulting in an operating margin of 0.3%.
BIO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Bio-Rad Laboratories, Inc. reported a net income of -527.10M and revenue of 592.10M, resulting in a net margin of -89.0%.
BA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, The Boeing Company reported a net income of -444.00M and revenue of 24.56B, resulting in a net margin of -1.8%.
Frequently Asked Questions
BIO and BA have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BA has higher volatility (10.83%) compared to BIO (8.54%). In terms of maximum drawdown, BIO dropped -83.64% vs BA's -89.45%.
BIO currently has the higher Sharpe Ratio (0.83 vs -0.08), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIO and BA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer